Prediction of induction and duration of complete remission in acute myelogenous leukemia: value of clonogenic cell properties.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003114:Colony-Forming Units Assay; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000473:pathology*; D011379:Prognosis; D012074:Remission Induction; D014410:Tumor Stem Cell Assay
D003561:Cytarabine; D003630:Daunorubicin